Isoprenylation of Intracellular Proteins as a New Target for the Therapy of Human Neoplasms: Preclinical and Clinical Implications

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|6|3|301-323

ISSN： 1389-4501

Source： Current Drug Targets, Vol.6, Iss.3, 2005-05, pp. : 301-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Hematopoietic Stem Cells in Gene Therapy: Pre-Clinical and Clinical Issues

By  

Current Gene Therapy, Vol. 8, Iss. 2, 2008-04 ,pp. : 135-146

Bentham Science Publishers

Access to resources Recommend Favorite

Pulmonary Coagulopathy as a New Target in Lung Injury - A Review of Available Pre-Clinical Models

By  

Current Medicinal Chemistry, Vol. 15, Iss. 6, 2008-03 ,pp. : 588-595

Bentham Science Publishers

Access to resources Recommend Favorite

Electroporation Gene Therapy Preclinical and Clinical Trials for Melanoma

By  

Current Gene Therapy, Vol. 10, Iss. 4, 2010-08 ,pp. : 312-317

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Development of New Therapy for Glycogen Storage Diseases

By  

Current Gene Therapy, Vol. 15, Iss. 4, 2015-01 ,pp. : 338-347

Bentham Science Publishers

Access to resources Recommend Favorite

Target Driven Preclinical Screening for New Antimitotic Chemotherapy Agents

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 20, 2014-10 ,pp. : 2263-2271

Bentham Science Publishers

Access to resources Recommend Favorite